DRAP-linked licence identifiersShown as recorded in linked source rows; not a claim of current validity.
DML000742
10 linked products · source seen 10 Aug 2026
View source ↗
Location intelligence
Company location
Google Maps
⌖Exact site not yet verified
MedInfoBase will not invent a factory or office location. The map appears after a sourced address, Place ID or verified embed URL is added.
Open in Google Maps ↗ The Google Maps search link uses the company name and available city/country context; it is not presented as a verified premises pin.
Intelligence snapshot
Portfolio at a glance
Not sales data · current MedInfoBase database view
Rx10product presentations
G3generic molecules
DF2dosage-form groups
TA2therapeutic areas
PKR10current price records
REG4registration numbers
Data coverage
How complete is this profile?
Current price coverage100%
products with a current official price
Source-linked coverage100%
products linked back to a source record
Unit-price parse coverage100%
priced packs safely normalized per unit
Comparable-market coverage90%
products with at least one like-for-like comparator
Therapeutic classification100%
products assigned to a broad therapeutic area
Visual intelligence
Downloadable company intelligence charts
Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.
Shareable intelligence
Therapeutic Portfolio Mix
Shows where the company portfolio is concentrated across broad therapeutic areas.
Portfolio distribution, not sales or market-share data.
Shareable intelligence
Dosage Form Portfolio
Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.
Counts are product presentations, not production or sales volumes.
Shareable intelligence
Equivalent-Market Price Position
Shows whether safely comparable products are below, near or above the market median unit price.
This is price-position intelligence, not sales, demand or market-share data.
Shareable intelligence
Closest Portfolio Competitors
Highlights other manufacturers with the greatest generic overlap with this company portfolio.
Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.
Portfolio intelligence
Therapeutic areas
Broad portfolio view
High-level clinical areas represented by this company’s current MedInfoBase portfolio.
MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.
Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.
Competitive landscape
Portfolio overlap
Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.
This page is generated from MedInfoBase medicine, generic, company, price and DRAP-source records. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.
Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.